Down-regulation	down-regulation	O	O	O	O
of	of	O	O	O	O
norepinephrine	norepinephrine	CHEMICALS	O	OTHERS	I
transporter	transporter	O	O	O	O
function	function	O	O	O	O
induced	induced	O	O	O	O
by	by	O	O	O	O
chronic	chronic	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
desipramine	desipramine	CHEMICALS	O	OTHERS	I
linking	linking	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
alteration	alteration	O	O	O	O
of	of	O	O	O	O
sensitivity	sensitivity	O	O	O	O
of	of	O	O	O	O
local-anesthetics-induced	local-anesthetics-induced	O	O	O	O
convulsions	convulsions	O	DISEASE	OTHERS	I
and	and	O	O	O	O
the	the	O	O	O	O
counteraction	counteraction	O	O	O	O
by	by	O	O	O	O
co-administration	co-administration	O	O	O	O
with	with	O	O	O	O
local	local	O	O	O	O
anesthetics	anesthetics	O	O	O	O
.	.	O	O	O	O

Alterations	alterations	O	O	O	O
of	of	O	O	O	O
norepinephrine	norepinephrine	CHEMICALS	O	OTHERS	I
transporter	transporter	O	O	O	O
(	(	O	O	O	O
NET	net	O	O	O	O
)	)	O	O	O	O
function	function	O	O	O	O
by	by	O	O	O	O
chronic	chronic	O	O	O	O
inhibition	inhibition	O	O	O	O
of	of	O	O	O	O
NET	net	O	O	O	O
in	in	O	O	O	O
relation	relation	O	O	O	O
to	to	O	O	O	O
sensitization	sensitization	O	O	O	O
to	to	O	O	O	O
seizures	seizures	O	DISEASE	OTHERS	I
induce	induce	O	O	O	O
by	by	O	O	O	O
cocaine	cocaine	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
local	local	O	O	O	O
anesthetics	anesthetics	O	O	O	O
were	were	O	O	O	O
studied	studied	O	O	O	O
in	in	O	O	O	O
mice	mice	O	O	O	O
.	.	O	O	O	O

Daily	daily	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
desipramine	desipramine	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
an	an	O	O	O	O
inhibitor	inhibitor	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
NET	net	O	O	O	O
,	,	O	O	O	O
for	for	O	O	O	O
5	5	O	O	O	O
days	days	O	O	O	O
decreased	decreased	O	O	O	O
[(3)H]norepinephrine	[(3)h]norepinephrine	O	O	O	O
uptake	uptake	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
P2	p2	O	O	O	O
fractions	fractions	O	O	O	O
of	of	O	O	O	O
hippocampus	hippocampus	O	O	O	O
but	but	O	O	O	O
not	not	O	O	O	O
cortex	cortex	O	O	O	O
,	,	O	O	O	O
striatum	striatum	O	O	O	O
or	or	O	O	O	O
amygdalae	amygdalae	O	O	O	O
.	.	O	O	O	O

Co-administration	co-administration	O	O	O	O
of	of	O	O	O	O
lidocaine	lidocaine	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
bupivacaine	bupivacaine	CHEMICALS	O	OTHERS	I
or	or	O	O	O	O
tricaine	tricaine	O	O	OTHERS	I
with	with	O	O	O	O
desipramine	desipramine	CHEMICALS	O	OTHERS	I
reversed	reversed	O	O	O	O
this	this	O	O	O	O
effect	effect	O	O	O	O
.	.	O	O	O	O

Daily	daily	O	O	O	O
treatment	treatment	O	O	O	O
of	of	O	O	O	O
cocaine	cocaine	CHEMICALS	O	OTHERS	I
increased	increased	O	O	O	O
[(3)H]norepinephrine	[(3)h]norepinephrine	O	O	O	O
uptake	uptake	O	O	O	O
into	into	O	O	O	O
the	the	O	O	O	O
hippocampus	hippocampus	O	O	O	O
.	.	O	O	O	O

Daily	daily	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
desipramine	desipramine	CHEMICALS	O	OTHERS	I
increased	increased	O	O	O	O
the	the	O	O	O	O
incidence	incidence	O	O	O	O
of	of	O	O	O	O
appearance	appearance	O	O	O	O
of	of	O	O	O	O
lidocaine-induced	lidocaine-induced	O	O	O	O
convulsions	convulsions	O	DISEASE	OTHERS	I
and	and	O	O	O	O
decreased	decreased	O	O	O	O
that	that	O	O	O	O
of	of	O	O	O	O
cocaine-induced	cocaine-induced	O	O	O	O
convulsions	convulsions	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Co-administration	co-administration	O	O	O	O
of	of	O	O	O	O
lidocaine	lidocaine	CHEMICALS	O	OTHERS	I
with	with	O	O	O	O
desipramine	desipramine	CHEMICALS	O	OTHERS	I
reversed	reversed	O	O	O	O
the	the	O	O	O	O
changes	changes	O	O	O	O
of	of	O	O	O	O
convulsive	convulsive	O	DISEASE	OTHERS	I
activity	activity	O	O	O	O
of	of	O	O	O	O
lidocaine	lidocaine	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
cocaine	cocaine	CHEMICALS	O	OTHERS	I
induced	induced	O	O	O	O
by	by	O	O	O	O
repeated	repeated	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
desipramine	desipramine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

These	these	O	O	O	O
results	results	O	O	O	O
suggest	suggest	O	O	O	O
that	that	O	O	O	O
down-regulation	down-regulation	O	O	O	O
of	of	O	O	O	O
hippocampal	hippocampal	O	O	O	O
NET	net	O	O	O	O
induced	induced	O	O	O	O
by	by	O	O	O	O
chronic	chronic	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
desipramine	desipramine	CHEMICALS	O	OTHERS	I
may	may	O	O	O	O
be	be	O	O	O	O
relevant	relevant	O	O	O	O
to	to	O	O	O	O
desipramine-induced	desipramine-induced	O	O	O	O
sensitization	sensitization	O	O	O	O
of	of	O	O	O	O
lidocaine	lidocaine	CHEMICALS	O	OTHERS	I
convulsions	convulsions	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Inhibition	inhibition	O	O	O	O
of	of	O	O	O	O
Na(+	na(+	O	O	O	O
)	)	O	O	O	O
channels	channels	O	O	O	O
by	by	O	O	O	O
local	local	O	O	O	O
anesthetics	anesthetics	O	O	O	O
may	may	O	O	O	O
regulate	regulate	O	O	O	O
desipramine-induced	desipramine-induced	O	O	O	O
down-regulation	down-regulation	O	O	O	O
of	of	O	O	O	O
NET	net	O	O	O	O
function	function	O	O	O	O
.	.	O	O	O	O

Repeated	repeated	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
cocaine	cocaine	CHEMICALS	O	OTHERS	I
induces	induces	O	O	O	O
up-regulation	up-regulation	O	O	O	O
of	of	O	O	O	O
hippocampal	hippocampal	O	O	O	O
NET	net	O	O	O	O
function	function	O	O	O	O
.	.	O	O	O	O

Desipramine-induced	desipramine-induced	O	O	O	O
sensitization	sensitization	O	O	O	O
of	of	O	O	O	O
lidocaine	lidocaine	CHEMICALS	O	OTHERS	I
seizures	seizures	O	DISEASE	OTHERS	I
may	may	O	O	O	O
have	have	O	O	O	O
a	a	O	O	O	O
mechanism	mechanism	O	O	O	O
distinct	distinct	O	O	O	O
from	from	O	O	O	O
kindling	kindling	O	O	O	O
resulting	resulting	O	O	O	O
from	from	O	O	O	O
repeated	repeated	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
cocaine	cocaine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

